Globus Medical Inc. logo

Globus Medical Inc. (GMED)

Market Closed
12 Jun, 20:00
NYSE NYSE
$
80. 39
-0.13
-0.1615%
$
10.84B Market Cap
48.4 P/E Ratio
- Div Yield
1.46M Volume
2.69 Eps
$ 80.52
Previous Close
Add Transaction
Day Range
79.81 80.87
Year Range
51.79 101.4
Want to track GMED and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Wall Street's Insights Into Key Metrics Ahead of Globus Medical (GMED) Q4 Earnings

Wall Street's Insights Into Key Metrics Ahead of Globus Medical (GMED) Q4 Earnings

Beyond analysts' top-and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.

Zacks | 3 months ago
Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth

Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth

Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 4 months ago
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term

Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 4 months ago
Here's Why Globus Medical (GMED) is a Strong Value Stock

Here's Why Globus Medical (GMED) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 4 months ago
GMED vs. PEN: Which Stock Is the Better Value Option?

GMED vs. PEN: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Penumbra (PEN). But which of these two stocks is more attractive to value investors?

Zacks | 4 months ago
Here's Why Globus Medical (GMED) is a Strong Momentum Stock

Here's Why Globus Medical (GMED) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 4 months ago
Here's Why Globus Medical (GMED) is a Strong Growth Stock

Here's Why Globus Medical (GMED) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 4 months ago
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?

Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?

Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 4 months ago
Should You Still Hold GMED Stock in Your Portfolio?

Should You Still Hold GMED Stock in Your Portfolio?

Globus Medical is growing musculoskeletal market share with new product launches, strong finances and international expansion plans.

Zacks | 4 months ago
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term

Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 5 months ago
Here's Why Globus Medical (GMED) is a Strong Growth Stock

Here's Why Globus Medical (GMED) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 5 months ago
3 Skyrocketing MedTech Stocks That Might Lose Steam in 2026

3 Skyrocketing MedTech Stocks That Might Lose Steam in 2026

Here are some surging MedTech stocks - GMED, TMDX and HIMS - that may face slowing momentum in 2026.

Zacks | 5 months ago
Loading...
Load More